Information Library
Results for: Oncology - Our Expertise
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Mapping the Future in Oncology Drug Development
White Paper — August 27, 2010
Industry veterans Harish Dave and Eric Groves summarize key findings of Quintiles’ ASCO Ancillary Event, Mapping the Future in Oncology Drug Development -
Patty James, B.S., MT (ASCP)
Bio — August 11, 2010
Patty James is an experienced relationship manager responsible for coordinating clinical trial logistics and operations for biomarker projects in oncology. -
Mapping the Future in Oncology Drug Development
Hear from the Experts — March 29, 2010
A world-renowned, multidisciplinary panel of experts to investigate challenges in, and propose strategies to enhance, oncology drug development. -
Integration of Molecular Biomarkers into Clinical Development
White Paper — March 29, 2010
Examining the challenges and opportunities in co-developing a biomarker and drug, this is the first white paper in a new series focusing on oncology. -
Data-Driven Patient Recruitment
White Paper — March 23, 2010
Under pressure to deliver more evidence faster, drug developers are constantly searching for more patients for clinical trials. -
Multinational Coordination
Case Study — February 26, 2010
Coordinating a non-Hodgkin’s lymphoma study across six countries, our expert team exceeded expectations for efficiency and communication. -
Key Trends in Multiple Myeloma Treatment
White Paper — February 26, 2010
An overview of the latest studies into novel drug combinations and new therapies in early stage testing in multiple myeloma. -
Biomarker Trends in Breast Cancer Research
White Paper — February 24, 2010
Dr. Hill discusses the implications and questions that will drive future R&D efforts to develop targeted breast cancer therapies. -
QUINTILES ADDS TISSUE TESTING SERVICES IN CHINA
Press Release — February 16, 2010 - Quintiles announced the availability of anatomic pathology services through its central laboratory in Beijing, China, to help biopharmaceutical companies develop more effective cancer treatments.
-
Contracting Timeline
Case Study — March 27, 2009
Aggressive Recruitment Speeds Time to Market. The goal: to accelerate a study of a top-priority drug for non-myeloid malignancy. Quintiles ramped up 36 sites in just two months.
